VLS Valneva SE

Valneva SE Shareholding Declaration - March 2025

Valneva SE Shareholding Declaration - March 2025

VALNEVA

Declaration of shares and voting rights

March 31, 2025

__________________________________________________________________________________________

Company name: VALNEVA

Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)

Regulated market of Euronext Paris - Compartment B

Declaration date: April 3, 2025

Number of shares

composing the share capital of Valneva 		Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**
 162,521,524



 ordinary shares with a par value of €0.15 each 		178,409,478 Double voting rights granted on 1,456 ordinary shares Between March 2 & March 28, 2025 178,285,156

___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

** Net (or exercisable at a General Meeting) voting rights.

Attachment



EN
03/04/2025

Underlying

VLSValneva SE

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Valneva SE

 PRESS RELEASE
Free
VLS VALNEVA SE

Valneva fait un point sur l’utilisation du vaccin IXCHIQ® au Royaume-...

Valneva fait un point sur l’utilisation du vaccin IXCHIQ® au Royaume-Uni Lyon (France), le 13 février 2026 –  (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui qu’à la suite d’une revue des bénéfices et risques du vaccin contre le chikungunya de la société, IXCHIQ®, la Commission britannique des médicaments à usage humain (CHM) a mis à jour ses recommandations concernant l’utilisation de ce vaccin. Les informations de prescription (PI) mises à jour refléteront ces recommandations, qui incluent désormais une restriction pour les personnes de...

February 13, 2026 1 EN
 PRESS RELEASE
Free
VLS VALNEVA SE

Valneva Provides Update on Recommendations for Use of IXCHIQ® in the U...

Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom Lyon (France), February 13, 2026 –  (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company’s single‑dose chikungunya vaccine, IXCHIQ®, the United Kingdom’s (UK) Commission on Human Medicines (CHM) has updated its recommendations for use of the vaccine. The updated Prescribing Information (PI) will reflect these recommendations, which now include a restriction for individuals over 60 years of age, for people with sp...

February 13, 2026 1 EN
 PRESS RELEASE
Free
VLS VALNEVA SE

VALNEVA Declaration of shares and voting rights: January 31, 2026

VALNEVA Declaration of shares and voting rights: January 31, 2026 VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name: VALNEVARegistered office: Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 LyonRegulated market of Euronext Paris - Compartment B Declaration date: correction as of February 11, 2026 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the change D...

February 11, 2026 1 EN
 PRESS RELEASE
Free
VLS VALNEVA SE

VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026

VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026 VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2026__________________________________________________________________________________________ Dénomination sociale : VALNEVAAdresse du siège social : Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 Lyon Marché réglementé Euronext Paris - Compartiment B Date de la déclaration : correctif au 11 février 2026 Nombre d’actions composant le capital de ValnevaNombre total de droits de vote incluant les droits de vote suspendus*Origin...

February 11, 2026 1 EN
 PRESS RELEASE
Free
VLS VALNEVA SE

VALNEVA Declaration of shares and voting rights: January 31, 2026

VALNEVA Declaration of shares and voting rights: January 31, 2026 VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name: VALNEVARegistered office: Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 LyonRegulated market of Euronext Paris - Compartment B Declaration date: February 6, 2026 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the change Date on which this c...

February 6, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch